ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peptide Conjugates Service Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-9B18479
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Peptide Conjugates Service Market Research Report 2024
BUY CHAPTERS

Global Peptide Conjugates Service Market Research Report 2024

Code: QYRE-Auto-9B18479
Report
October 2024
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Almac Group
Bio-Synthesis
Creative Peptides
ProtaGene GmbH
WuXi TIDES
Ajinomoto
Pharmaron
SBS Genetech
Creative Enzymes
AnaSpec
BOCSCI Inc.
JPT Peptide Technologies
Kaneka Eurogentec SA
QYAOBIO
Medtide Inc

Peptide Conjugates Service Market

Peptide Conjugates Service generally refer to professional services provided for the fields of biomedicine, pharmaceuticals or scientific research, involving the combination of peptides with oligonucleotides, carrier proteins, DNA, RNA and small molecules, and are widely used in biological research, clinical medicine and drug development.
The global Peptide Conjugates Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Peptide Conjugates Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Peptide Conjugates Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Peptide Conjugates Service in Vaccine Development is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Peptide Conjugates Service include Almac Group, Bio-Synthesis, Creative Peptides, ProtaGene GmbH, WuXi TIDES, Medtide Inc, Ajinomoto, PHARMARON, SBS Genetech, Creative Enzymes, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peptide Conjugates Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Conjugates Service.
The Peptide Conjugates Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peptide Conjugates Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Conjugates Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Peptide Conjugates Service Market Report

Report Metric Details
Report Name Peptide Conjugates Service Market
Segment by Type
Segment by Application
  • Vaccine Development
  • Drug Delivery
  • Biomarkers
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Almac Group, Bio-Synthesis, Creative Peptides, ProtaGene GmbH, WuXi TIDES, Medtide Inc, Ajinomoto, PHARMARON, SBS Genetech, Creative Enzymes, AnaSpec, BOCSCI Inc, JPT Peptide Technologies, Kaneka Eurogentec SA, QYAOBIO
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Peptide Conjugates Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Peptide Conjugates Service Market report?

Ans: The main players in the Peptide Conjugates Service Market are Almac Group, Bio-Synthesis, Creative Peptides, ProtaGene GmbH, WuXi TIDES, Medtide Inc, Ajinomoto, PHARMARON, SBS Genetech, Creative Enzymes, AnaSpec, BOCSCI Inc, JPT Peptide Technologies, Kaneka Eurogentec SA, QYAOBIO

What are the Application segmentation covered in the Peptide Conjugates Service Market report?

Ans: The Applications covered in the Peptide Conjugates Service Market report are Vaccine Development, Drug Delivery, Biomarkers

What are the Type segmentation covered in the Peptide Conjugates Service Market report?

Ans: The Types covered in the Peptide Conjugates Service Market report are Peptide Oligonucleotide Conjugates, Peptide Carrier Protein Conjugates, Peptide Small Molecule Conjugates, Other

Recommended Reports

Peptide Synthesis Services

Therapeutic Peptide Markets

Conjugate and ADC Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Conjugates Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Peptide Oligonucleotide Conjugates
1.2.3 Peptide Carrier Protein Conjugates
1.2.4 Peptide Small Molecule Conjugates
1.2.5 Other
1.3 Market by Application
1.3.1 Global Peptide Conjugates Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Vaccine Development
1.3.3 Drug Delivery
1.3.4 Biomarkers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Conjugates Service Market Perspective (2019-2030)
2.2 Global Peptide Conjugates Service Growth Trends by Region
2.2.1 Global Peptide Conjugates Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Peptide Conjugates Service Historic Market Size by Region (2019-2024)
2.2.3 Peptide Conjugates Service Forecasted Market Size by Region (2025-2030)
2.3 Peptide Conjugates Service Market Dynamics
2.3.1 Peptide Conjugates Service Industry Trends
2.3.2 Peptide Conjugates Service Market Drivers
2.3.3 Peptide Conjugates Service Market Challenges
2.3.4 Peptide Conjugates Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Conjugates Service Players by Revenue
3.1.1 Global Top Peptide Conjugates Service Players by Revenue (2019-2024)
3.1.2 Global Peptide Conjugates Service Revenue Market Share by Players (2019-2024)
3.2 Global Peptide Conjugates Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peptide Conjugates Service Revenue
3.4 Global Peptide Conjugates Service Market Concentration Ratio
3.4.1 Global Peptide Conjugates Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Conjugates Service Revenue in 2023
3.5 Global Key Players of Peptide Conjugates Service Head office and Area Served
3.6 Global Key Players of Peptide Conjugates Service, Product and Application
3.7 Global Key Players of Peptide Conjugates Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Conjugates Service Breakdown Data by Type
4.1 Global Peptide Conjugates Service Historic Market Size by Type (2019-2024)
4.2 Global Peptide Conjugates Service Forecasted Market Size by Type (2025-2030)
5 Peptide Conjugates Service Breakdown Data by Application
5.1 Global Peptide Conjugates Service Historic Market Size by Application (2019-2024)
5.2 Global Peptide Conjugates Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Peptide Conjugates Service Market Size (2019-2030)
6.2 North America Peptide Conjugates Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Peptide Conjugates Service Market Size by Country (2019-2024)
6.4 North America Peptide Conjugates Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide Conjugates Service Market Size (2019-2030)
7.2 Europe Peptide Conjugates Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Peptide Conjugates Service Market Size by Country (2019-2024)
7.4 Europe Peptide Conjugates Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Conjugates Service Market Size (2019-2030)
8.2 Asia-Pacific Peptide Conjugates Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Peptide Conjugates Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Peptide Conjugates Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide Conjugates Service Market Size (2019-2030)
9.2 Latin America Peptide Conjugates Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Peptide Conjugates Service Market Size by Country (2019-2024)
9.4 Latin America Peptide Conjugates Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Conjugates Service Market Size (2019-2030)
10.2 Middle East & Africa Peptide Conjugates Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Peptide Conjugates Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Peptide Conjugates Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Almac Group
11.1.1 Almac Group Company Details
11.1.2 Almac Group Business Overview
11.1.3 Almac Group Peptide Conjugates Service Introduction
11.1.4 Almac Group Revenue in Peptide Conjugates Service Business (2019-2024)
11.1.5 Almac Group Recent Development
11.2 Bio-Synthesis
11.2.1 Bio-Synthesis Company Details
11.2.2 Bio-Synthesis Business Overview
11.2.3 Bio-Synthesis Peptide Conjugates Service Introduction
11.2.4 Bio-Synthesis Revenue in Peptide Conjugates Service Business (2019-2024)
11.2.5 Bio-Synthesis Recent Development
11.3 Creative Peptides
11.3.1 Creative Peptides Company Details
11.3.2 Creative Peptides Business Overview
11.3.3 Creative Peptides Peptide Conjugates Service Introduction
11.3.4 Creative Peptides Revenue in Peptide Conjugates Service Business (2019-2024)
11.3.5 Creative Peptides Recent Development
11.4 ProtaGene GmbH
11.4.1 ProtaGene GmbH Company Details
11.4.2 ProtaGene GmbH Business Overview
11.4.3 ProtaGene GmbH Peptide Conjugates Service Introduction
11.4.4 ProtaGene GmbH Revenue in Peptide Conjugates Service Business (2019-2024)
11.4.5 ProtaGene GmbH Recent Development
11.5 WuXi TIDES
11.5.1 WuXi TIDES Company Details
11.5.2 WuXi TIDES Business Overview
11.5.3 WuXi TIDES Peptide Conjugates Service Introduction
11.5.4 WuXi TIDES Revenue in Peptide Conjugates Service Business (2019-2024)
11.5.5 WuXi TIDES Recent Development
11.6 Medtide Inc
11.6.1 Medtide Inc Company Details
11.6.2 Medtide Inc Business Overview
11.6.3 Medtide Inc Peptide Conjugates Service Introduction
11.6.4 Medtide Inc Revenue in Peptide Conjugates Service Business (2019-2024)
11.6.5 Medtide Inc Recent Development
11.7 Ajinomoto
11.7.1 Ajinomoto Company Details
11.7.2 Ajinomoto Business Overview
11.7.3 Ajinomoto Peptide Conjugates Service Introduction
11.7.4 Ajinomoto Revenue in Peptide Conjugates Service Business (2019-2024)
11.7.5 Ajinomoto Recent Development
11.8 PHARMARON
11.8.1 PHARMARON Company Details
11.8.2 PHARMARON Business Overview
11.8.3 PHARMARON Peptide Conjugates Service Introduction
11.8.4 PHARMARON Revenue in Peptide Conjugates Service Business (2019-2024)
11.8.5 PHARMARON Recent Development
11.9 SBS Genetech
11.9.1 SBS Genetech Company Details
11.9.2 SBS Genetech Business Overview
11.9.3 SBS Genetech Peptide Conjugates Service Introduction
11.9.4 SBS Genetech Revenue in Peptide Conjugates Service Business (2019-2024)
11.9.5 SBS Genetech Recent Development
11.10 Creative Enzymes
11.10.1 Creative Enzymes Company Details
11.10.2 Creative Enzymes Business Overview
11.10.3 Creative Enzymes Peptide Conjugates Service Introduction
11.10.4 Creative Enzymes Revenue in Peptide Conjugates Service Business (2019-2024)
11.10.5 Creative Enzymes Recent Development
11.11 AnaSpec
11.11.1 AnaSpec Company Details
11.11.2 AnaSpec Business Overview
11.11.3 AnaSpec Peptide Conjugates Service Introduction
11.11.4 AnaSpec Revenue in Peptide Conjugates Service Business (2019-2024)
11.11.5 AnaSpec Recent Development
11.12 BOCSCI Inc
11.12.1 BOCSCI Inc Company Details
11.12.2 BOCSCI Inc Business Overview
11.12.3 BOCSCI Inc Peptide Conjugates Service Introduction
11.12.4 BOCSCI Inc Revenue in Peptide Conjugates Service Business (2019-2024)
11.12.5 BOCSCI Inc Recent Development
11.13 JPT Peptide Technologies
11.13.1 JPT Peptide Technologies Company Details
11.13.2 JPT Peptide Technologies Business Overview
11.13.3 JPT Peptide Technologies Peptide Conjugates Service Introduction
11.13.4 JPT Peptide Technologies Revenue in Peptide Conjugates Service Business (2019-2024)
11.13.5 JPT Peptide Technologies Recent Development
11.14 Kaneka Eurogentec SA
11.14.1 Kaneka Eurogentec SA Company Details
11.14.2 Kaneka Eurogentec SA Business Overview
11.14.3 Kaneka Eurogentec SA Peptide Conjugates Service Introduction
11.14.4 Kaneka Eurogentec SA Revenue in Peptide Conjugates Service Business (2019-2024)
11.14.5 Kaneka Eurogentec SA Recent Development
11.15 QYAOBIO
11.15.1 QYAOBIO Company Details
11.15.2 QYAOBIO Business Overview
11.15.3 QYAOBIO Peptide Conjugates Service Introduction
11.15.4 QYAOBIO Revenue in Peptide Conjugates Service Business (2019-2024)
11.15.5 QYAOBIO Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Almac Group
Bio-Synthesis
Creative Peptides
ProtaGene GmbH
WuXi TIDES
Ajinomoto
Pharmaron
SBS Genetech
Creative Enzymes
AnaSpec
BOCSCI Inc.
JPT Peptide Technologies
Kaneka Eurogentec SA
QYAOBIO
Medtide Inc
List of Tables
 Table 1. Global Peptide Conjugates Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Peptide Oligonucleotide Conjugates
 Table 3. Key Players of Peptide Carrier Protein Conjugates
 Table 4. Key Players of Peptide Small Molecule Conjugates
 Table 5. Key Players of Other
 Table 6. Global Peptide Conjugates Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Peptide Conjugates Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 8. Global Peptide Conjugates Service Market Size by Region (2019-2024) & (US$ Million)
 Table 9. Global Peptide Conjugates Service Market Share by Region (2019-2024)
 Table 10. Global Peptide Conjugates Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 11. Global Peptide Conjugates Service Market Share by Region (2025-2030)
 Table 12. Peptide Conjugates Service Market Trends
 Table 13. Peptide Conjugates Service Market Drivers
 Table 14. Peptide Conjugates Service Market Challenges
 Table 15. Peptide Conjugates Service Market Restraints
 Table 16. Global Peptide Conjugates Service Revenue by Players (2019-2024) & (US$ Million)
 Table 17. Global Peptide Conjugates Service Market Share by Players (2019-2024)
 Table 18. Global Top Peptide Conjugates Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Conjugates Service as of 2023)
 Table 19. Ranking of Global Top Peptide Conjugates Service Companies by Revenue (US$ Million) in 2023
 Table 20. Global 5 Largest Players Market Share by Peptide Conjugates Service Revenue (CR5 and HHI) & (2019-2024)
 Table 21. Global Key Players of Peptide Conjugates Service, Headquarters and Area Served
 Table 22. Global Key Players of Peptide Conjugates Service, Product and Application
 Table 23. Global Key Players of Peptide Conjugates Service, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Peptide Conjugates Service Market Size by Type (2019-2024) & (US$ Million)
 Table 26. Global Peptide Conjugates Service Revenue Market Share by Type (2019-2024)
 Table 27. Global Peptide Conjugates Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 28. Global Peptide Conjugates Service Revenue Market Share by Type (2025-2030)
 Table 29. Global Peptide Conjugates Service Market Size by Application (2019-2024) & (US$ Million)
 Table 30. Global Peptide Conjugates Service Revenue Market Share by Application (2019-2024)
 Table 31. Global Peptide Conjugates Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 32. Global Peptide Conjugates Service Revenue Market Share by Application (2025-2030)
 Table 33. North America Peptide Conjugates Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 34. North America Peptide Conjugates Service Market Size by Country (2019-2024) & (US$ Million)
 Table 35. North America Peptide Conjugates Service Market Size by Country (2025-2030) & (US$ Million)
 Table 36. Europe Peptide Conjugates Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 37. Europe Peptide Conjugates Service Market Size by Country (2019-2024) & (US$ Million)
 Table 38. Europe Peptide Conjugates Service Market Size by Country (2025-2030) & (US$ Million)
 Table 39. Asia-Pacific Peptide Conjugates Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 40. Asia-Pacific Peptide Conjugates Service Market Size by Region (2019-2024) & (US$ Million)
 Table 41. Asia-Pacific Peptide Conjugates Service Market Size by Region (2025-2030) & (US$ Million)
 Table 42. Latin America Peptide Conjugates Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Latin America Peptide Conjugates Service Market Size by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Peptide Conjugates Service Market Size by Country (2025-2030) & (US$ Million)
 Table 45. Middle East & Africa Peptide Conjugates Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 46. Middle East & Africa Peptide Conjugates Service Market Size by Country (2019-2024) & (US$ Million)
 Table 47. Middle East & Africa Peptide Conjugates Service Market Size by Country (2025-2030) & (US$ Million)
 Table 48. Almac Group Company Details
 Table 49. Almac Group Business Overview
 Table 50. Almac Group Peptide Conjugates Service Product
 Table 51. Almac Group Revenue in Peptide Conjugates Service Business (2019-2024) & (US$ Million)
 Table 52. Almac Group Recent Development
 Table 53. Bio-Synthesis Company Details
 Table 54. Bio-Synthesis Business Overview
 Table 55. Bio-Synthesis Peptide Conjugates Service Product
 Table 56. Bio-Synthesis Revenue in Peptide Conjugates Service Business (2019-2024) & (US$ Million)
 Table 57. Bio-Synthesis Recent Development
 Table 58. Creative Peptides Company Details
 Table 59. Creative Peptides Business Overview
 Table 60. Creative Peptides Peptide Conjugates Service Product
 Table 61. Creative Peptides Revenue in Peptide Conjugates Service Business (2019-2024) & (US$ Million)
 Table 62. Creative Peptides Recent Development
 Table 63. ProtaGene GmbH Company Details
 Table 64. ProtaGene GmbH Business Overview
 Table 65. ProtaGene GmbH Peptide Conjugates Service Product
 Table 66. ProtaGene GmbH Revenue in Peptide Conjugates Service Business (2019-2024) & (US$ Million)
 Table 67. ProtaGene GmbH Recent Development
 Table 68. WuXi TIDES Company Details
 Table 69. WuXi TIDES Business Overview
 Table 70. WuXi TIDES Peptide Conjugates Service Product
 Table 71. WuXi TIDES Revenue in Peptide Conjugates Service Business (2019-2024) & (US$ Million)
 Table 72. WuXi TIDES Recent Development
 Table 73. Medtide Inc Company Details
 Table 74. Medtide Inc Business Overview
 Table 75. Medtide Inc Peptide Conjugates Service Product
 Table 76. Medtide Inc Revenue in Peptide Conjugates Service Business (2019-2024) & (US$ Million)
 Table 77. Medtide Inc Recent Development
 Table 78. Ajinomoto Company Details
 Table 79. Ajinomoto Business Overview
 Table 80. Ajinomoto Peptide Conjugates Service Product
 Table 81. Ajinomoto Revenue in Peptide Conjugates Service Business (2019-2024) & (US$ Million)
 Table 82. Ajinomoto Recent Development
 Table 83. PHARMARON Company Details
 Table 84. PHARMARON Business Overview
 Table 85. PHARMARON Peptide Conjugates Service Product
 Table 86. PHARMARON Revenue in Peptide Conjugates Service Business (2019-2024) & (US$ Million)
 Table 87. PHARMARON Recent Development
 Table 88. SBS Genetech Company Details
 Table 89. SBS Genetech Business Overview
 Table 90. SBS Genetech Peptide Conjugates Service Product
 Table 91. SBS Genetech Revenue in Peptide Conjugates Service Business (2019-2024) & (US$ Million)
 Table 92. SBS Genetech Recent Development
 Table 93. Creative Enzymes Company Details
 Table 94. Creative Enzymes Business Overview
 Table 95. Creative Enzymes Peptide Conjugates Service Product
 Table 96. Creative Enzymes Revenue in Peptide Conjugates Service Business (2019-2024) & (US$ Million)
 Table 97. Creative Enzymes Recent Development
 Table 98. AnaSpec Company Details
 Table 99. AnaSpec Business Overview
 Table 100. AnaSpec Peptide Conjugates Service Product
 Table 101. AnaSpec Revenue in Peptide Conjugates Service Business (2019-2024) & (US$ Million)
 Table 102. AnaSpec Recent Development
 Table 103. BOCSCI Inc Company Details
 Table 104. BOCSCI Inc Business Overview
 Table 105. BOCSCI Inc Peptide Conjugates Service Product
 Table 106. BOCSCI Inc Revenue in Peptide Conjugates Service Business (2019-2024) & (US$ Million)
 Table 107. BOCSCI Inc Recent Development
 Table 108. JPT Peptide Technologies Company Details
 Table 109. JPT Peptide Technologies Business Overview
 Table 110. JPT Peptide Technologies Peptide Conjugates Service Product
 Table 111. JPT Peptide Technologies Revenue in Peptide Conjugates Service Business (2019-2024) & (US$ Million)
 Table 112. JPT Peptide Technologies Recent Development
 Table 113. Kaneka Eurogentec SA Company Details
 Table 114. Kaneka Eurogentec SA Business Overview
 Table 115. Kaneka Eurogentec SA Peptide Conjugates Service Product
 Table 116. Kaneka Eurogentec SA Revenue in Peptide Conjugates Service Business (2019-2024) & (US$ Million)
 Table 117. Kaneka Eurogentec SA Recent Development
 Table 118. QYAOBIO Company Details
 Table 119. QYAOBIO Business Overview
 Table 120. QYAOBIO Peptide Conjugates Service Product
 Table 121. QYAOBIO Revenue in Peptide Conjugates Service Business (2019-2024) & (US$ Million)
 Table 122. QYAOBIO Recent Development
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Peptide Conjugates Service Picture
 Figure 2. Global Peptide Conjugates Service Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Peptide Conjugates Service Market Share by Type: 2023 VS 2030
 Figure 4. Peptide Oligonucleotide Conjugates Features
 Figure 5. Peptide Carrier Protein Conjugates Features
 Figure 6. Peptide Small Molecule Conjugates Features
 Figure 7. Other Features
 Figure 8. Global Peptide Conjugates Service Market Size by Application (2024-2030) & (US$ Million)
 Figure 9. Global Peptide Conjugates Service Market Share by Application: 2023 VS 2030
 Figure 10. Vaccine Development Case Studies
 Figure 11. Drug Delivery Case Studies
 Figure 12. Biomarkers Case Studies
 Figure 13. Peptide Conjugates Service Report Years Considered
 Figure 14. Global Peptide Conjugates Service Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 15. Global Peptide Conjugates Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Peptide Conjugates Service Market Share by Region: 2023 VS 2030
 Figure 17. Global Peptide Conjugates Service Market Share by Players in 2023
 Figure 18. Global Top Peptide Conjugates Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Conjugates Service as of 2023)
 Figure 19. The Top 10 and 5 Players Market Share by Peptide Conjugates Service Revenue in 2023
 Figure 20. North America Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. North America Peptide Conjugates Service Market Share by Country (2019-2030)
 Figure 22. United States Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Canada Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Peptide Conjugates Service Market Share by Country (2019-2030)
 Figure 26. Germany Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Peptide Conjugates Service Market Share by Region (2019-2030)
 Figure 34. China Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Japan Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. South Korea Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Southeast Asia Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. India Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Australia Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Peptide Conjugates Service Market Share by Country (2019-2030)
 Figure 42. Mexico Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Brazil Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Peptide Conjugates Service Market Share by Country (2019-2030)
 Figure 46. Turkey Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Saudi Arabia Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. UAE Peptide Conjugates Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Almac Group Revenue Growth Rate in Peptide Conjugates Service Business (2019-2024)
 Figure 50. Bio-Synthesis Revenue Growth Rate in Peptide Conjugates Service Business (2019-2024)
 Figure 51. Creative Peptides Revenue Growth Rate in Peptide Conjugates Service Business (2019-2024)
 Figure 52. ProtaGene GmbH Revenue Growth Rate in Peptide Conjugates Service Business (2019-2024)
 Figure 53. WuXi TIDES Revenue Growth Rate in Peptide Conjugates Service Business (2019-2024)
 Figure 54. Medtide Inc Revenue Growth Rate in Peptide Conjugates Service Business (2019-2024)
 Figure 55. Ajinomoto Revenue Growth Rate in Peptide Conjugates Service Business (2019-2024)
 Figure 56. PHARMARON Revenue Growth Rate in Peptide Conjugates Service Business (2019-2024)
 Figure 57. SBS Genetech Revenue Growth Rate in Peptide Conjugates Service Business (2019-2024)
 Figure 58. Creative Enzymes Revenue Growth Rate in Peptide Conjugates Service Business (2019-2024)
 Figure 59. AnaSpec Revenue Growth Rate in Peptide Conjugates Service Business (2019-2024)
 Figure 60. BOCSCI Inc Revenue Growth Rate in Peptide Conjugates Service Business (2019-2024)
 Figure 61. JPT Peptide Technologies Revenue Growth Rate in Peptide Conjugates Service Business (2019-2024)
 Figure 62. Kaneka Eurogentec SA Revenue Growth Rate in Peptide Conjugates Service Business (2019-2024)
 Figure 63. QYAOBIO Revenue Growth Rate in Peptide Conjugates Service Business (2019-2024)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Oligonucleotide Bioconjugation Service Market Research Report 2024
Global Peptide Carrier Protein Conjugates Market Research Report 2024
Global Pharmaceutical Peptides Services Market Research Report 2025
Global Cyclic Peptide Service Market Research Report 2024
Global Peptide Analysis Services Market Research Report 2025
Global Peptide Manufacturing and Development Services Market Research Report 2024
Peptide Drug Conjugates Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide Microarray Service Market Research Report 2024
Global Peptide and Oligonucleotide Drugs Market Research Report 2024
Global Peptide Therapy Market Research Report 2025
Global Modified Peptide Synthesis Services Market Research Report 2025
Global Peptide Antibody Conjugate PAC Market Research Report 2024
Global Peptide PNA Peptide nucleic acid Conjugate Market Research Report 2024
Global Custom Peptide Synthesis Service Market Insights Forecast to 2030
Global Peptide Screening Service Market Research Report 2025
Global Customized Peptide Synthesis Service Market Research Report 2024
Global Protein Conjugation Services Market Research Report 2024
Global Targeting Peptides Market Research Report 2024
Global Oligonucleotide Conjugates Market Research Report 2024
Global Peptide Based Cancer Therapeutics Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions